Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.
about
Quo vadis motor neuron disease?Molybdenum Deficiency Produces Motor Nervous Effects That Are Consistent with Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsMicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosisEmerging mechanisms of molecular pathology in ALSWhat causes amyotrophic lateral sclerosis?Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron diseaseAccuracy of routinely-collected healthcare data for identifying motor neurone disease cases: A systematic reviewEstablishing the UK DNA Bank for motor neuron disease (MND).Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective studyPrevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients.Current pathways for epidemiological research in amyotrophic lateral sclerosis.Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.Incidence of and risk factors for motor neurone disease in UK women: a prospective study.A fruitful endeavor: modeling ALS in the fruit flyThe contribution of genetic variants to disease depends on the rulerLeaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse modelNeurological deaths of American adults (55-74) and the over 75's by sex compared with 20 Western countries 1989-2010: Cause for concern.Investigating Default Mode and Sensorimotor Network Connectivity in Amyotrophic Lateral Sclerosis.Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromesProjected increase in amyotrophic lateral sclerosis from 2015 to 2040The patient experience of fatigue in motor neurone disease.The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.Is head trauma a risk factor for amyotrophic lateral sclerosis? An evidence based review.Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.The X-Linked Hypothesis of Brain Disorders: Can Gender Ratios Tell Us Anything About Cellular Etiology of Neurodegenerative and Psychiatric Diseases?Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis.Enteral feeding in neurological disorders.Nationwide incidence of motor neuron disease using the French health insurance information system database.Lived-through past, experienced present, anticipated future: Understanding "existential loss" in the context of life-limiting illness.The anatomy and physiology of normal and abnormal swallowing in oropharyngeal dysphagia.Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study.Puzzles in modern biology. IV. Neurodegeneration, localized origin and widespread decay.Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.Amyotrophic Lateral Sclerosis: An Acupuncture Approach.
P2860
Q26750561-44B8FD58-0C0D-4CE0-93C1-C532AD4E50EDQ26751081-BE58327A-4B1C-408C-ADAB-1F8E93538A76Q27021917-D6D02343-CD76-4CC6-94EF-FE9C02DCE12BQ27321524-D2AA2706-923D-4AC0-8B8C-4277ED709287Q28081239-B1D08C47-5896-4468-AE17-B5C6CD1EC1CAQ30234813-711FC282-79F3-492F-855A-8A40252C4C7EQ30463799-469E7546-3ED1-49EF-B4CD-E9925CF0E2F9Q31168074-445B2DB0-E6BD-48DA-A12B-E99745ACE780Q33457510-26D6D53C-68FB-4D19-93DF-E2B86BC946D2Q33523900-7EF10C24-62F3-4B77-AA13-077F7390BC98Q33562103-04F70B64-4267-4B59-866B-875DBE2E0C14Q33697436-6AB62695-410C-4009-849B-65126F6755F8Q34099212-1463F0D5-0734-4377-B860-61AB4E4142E2Q34257763-877FAAC3-470F-4449-BEFE-1BFEA315440FQ35268719-9E929A4F-F12E-42E3-A559-21A5FAFB69C4Q35547325-511663A8-71A9-4CD9-94C7-DDE411DEAF71Q35588631-3267CF18-010C-4FD8-8836-7C827C905CF4Q35905910-2ABE08DE-E836-4199-9D8A-141067D4C9EEQ36056648-F8BA517D-3EA0-4D4F-935F-C4EE813EF84FQ36202825-294B969F-047F-448E-ADA3-B3DDF0E22393Q36403811-1F78466D-70DA-4154-A6C3-AE15B7C1F18CQ36666933-4F3BC983-2BCC-48D6-973E-7FA781A576F4Q36862751-C37767B7-833D-4207-A467-066545A0277EQ37181233-25EC67DD-7C32-4834-96BF-B56BD4C66735Q37620438-3AA21345-5E6F-4723-8030-6194B29B09FEQ37926529-2FA667AD-3FD5-4F99-8C23-7F6C698DCA95Q37931374-DBE0CD3F-EA10-4B9A-973F-B5E2D4809689Q37957674-952247A0-9D11-4335-B6A0-6BF06139C26FQ37994257-B7A94DBC-4A1C-4E5D-854D-0912EE546881Q38091029-4DAA9B07-B856-4318-9DDB-F7D1BB66EFB3Q38238242-CBE229F2-4CBF-43C2-9E92-0257ADBD8CC2Q38557126-AB3F72C0-D0D0-463C-B2FD-FA5217D6FE16Q38827351-85BDB30F-7252-4D2C-827F-2457BC0885ACQ38848520-BB74A63B-2AC9-4A53-914D-5879078E47A9Q38996916-D21B8AEC-8346-4563-A261-8A892732ABFEQ39332137-9E30DEDF-BAF9-4E10-8138-921A335F13B3Q39430589-57A9631C-9F76-4380-885C-FD19C1ADC180Q40341875-9220ADBF-A3CA-47DC-B374-4BD311C524DAQ42265210-2E6CCA19-E037-49E7-80FF-51CA3EFC3351Q42647768-039E2520-9BDB-48FF-8570-13C86F46B2A8
P2860
Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Incidence and lifetime risk of ...... dom: a population-based study.
@ast
Incidence and lifetime risk of ...... dom: a population-based study.
@en
Incidence and lifetime risk of ...... dom: a population-based study.
@nl
type
label
Incidence and lifetime risk of ...... dom: a population-based study.
@ast
Incidence and lifetime risk of ...... dom: a population-based study.
@en
Incidence and lifetime risk of ...... dom: a population-based study.
@nl
prefLabel
Incidence and lifetime risk of ...... dom: a population-based study.
@ast
Incidence and lifetime risk of ...... dom: a population-based study.
@en
Incidence and lifetime risk of ...... dom: a population-based study.
@nl
P2860
P1476
Incidence and lifetime risk of ...... gdom: a population-based study
@en
P2093
G Logroscino
M A Hernán
P2860
P304
P356
10.1111/J.1468-1331.2009.02586.X
P577
2009-06-01T00:00:00Z